Madhav Seshadri, MD

Title(s)Assistant Professor, Medicine
SchoolSchool of Medicine
Address400 Parnassus Avenue
San Francisco CA 94117
Phone--
ORCID ORCID Icon0000-0001-5106-1979 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    New York-Presbyterian Hospital, Weill Cornell Medicine, New York, NY07/2022Fellowship in Hematology and Oncology
    New York-Presbyterian Hospital, Weill Cornell Medicine, New York, NY07/2019Residency in Internal Medicine
    Emory University School of Medicine, Atlanta, GAMD05/2016
    Collapse Awards and Honors
    American Society of Hematology2021Abstract Achievement Award
    American Society of Hematology2021  - 2022Research Training Award for Fellows
    Emory University School of Medicine2015  - 2016Ann Hoyt Jolley Merit Scholarship

    Collapse Overview 
    Collapse Overview
    I take care of people with lymphoma and chronic lymphocytic leukemia. I believe in taking an individualized approach to each patient's care. By understanding their values and priorities, together we will arrive at the best treatment plan.

    I graduated with honors from Emory University School of Medicine in Atlanta. I completed residency in Internal Medicine and fellowship in Hematology and Oncology at New York Presbyterian Hospital/Weill Cornell Medical Center in New York, where I also served as Chief Fellow. At UCSF I am fortunate to practice at a leading medical center which is at the forefront of cancer care.

    Technologies for the diagnosis and treatment of lymphoma and CLL are rapidly evolving, and I will use the latest advancements in providing care for patients. We are also fortunate to have a strong team of specialty consultants, nurse practitioners, nurses, medical technicians, pharmacists, and administrative staff. It would be a privilege to care for you or your family member.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Premortem Skin Biopsy Assessing Microthrombi, Interferon Type I Antiviral and Regulatory Proteins, and Complement Deposition Correlates with Coronavirus Disease 2019 Clinical Stage. Am J Pathol. 2022 09; 192(9):1282-1294. Laurence J, Nuovo G, Racine-Brzostek SE, Seshadri M, Elhadad S, Crowson AN, Mulvey JJ, Harp J, Ahamed J, Magro C. PMID: 35640675; PMCID: PMC9144849.
      View in: PubMed   Mentions:    Fields:    
    2. Targeting MALT1 for the treatment of diffuse large B-cell lymphoma. Leuk Lymphoma. 2022 04; 63(4):789-798. Seshadri MR, Melnick AM. PMID: 34783281.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    3. Clinical outcomes in eight patients with immune thrombocytopenia each treated with the three approved thrombopoietin receptor agonists. Am J Hematol. 2021 10 01; 96(10):E373-E376. Lee EJ, Seshadri M, Bussel JB. PMID: 34152624.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19. Clin Immunol. 2020 10; 219:108555. Laurence J, Mulvey JJ, Seshadri M, Racanelli A, Harp J, Schenck EJ, Zappetti D, Horn EM, Magro CM. PMID: 32771488; PMCID: PMC7410014.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCellsPHPublic Health
    5. Ofatumumab for post-transplant lymphoproliferative disorder. Hematol Oncol Stem Cell Ther. 2020 May 11. Seshadri M, Crane GM, Gergis U. PMID: 32413419.
      View in: PubMed   Mentions: 1     Fields:    
    6. Microenvironmental regulation of hematopoietic stem cells and its implications in leukemogenesis. Curr Opin Hematol. 2016 07; 23(4):339-45. Seshadri M, Qu CK. PMID: 27071022; PMCID: PMC5086033.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    7. Image-guided thermal therapy with a dual-contrast magnetic nanoparticle formulation: A feasibility study. Int J Hyperthermia. 2016 08; 32(5):543-57. Attaluri A, Seshadri M, Mirpour S, Wabler M, Marinho T, Furqan M, Zhou H, De Paoli S, Gruettner C, Gilson W, DeWeese T, Garcia M, Ivkov R, Liapi E. PMID: 27151045; PMCID: PMC4936948.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    8. Snapin mediates incretin action and augments glucose-dependent insulin secretion. Cell Metab. 2011 Mar 02; 13(3):308-19. Song WJ, Seshadri M, Ashraf U, Mdluli T, Mondal P, Keil M, Azevedo M, Kirschner LS, Stratakis CA, Hussain MA. PMID: 21356520; PMCID: PMC3053597.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansAnimalsCells